Company Filing History:
Years Active: 2014
Title: Loany Calvo Gonzalez: Innovator in Vaccine Development
Introduction
Loany Calvo Gonzalez is a notable inventor based in Havana, Cuba. He has made significant contributions to the field of immunology, particularly in the development of vaccine compositions for cancer treatment. His innovative approach has the potential to enhance therapeutic options for patients suffering from tumors.
Latest Patents
Loany Calvo Gonzalez holds a patent for a "Method for making a homogenous vaccine composition comprising a conjugate of EGF and 64K for the treatment of tumors." This vaccine composition is designed for therapeutic use in cancer patients and includes a chemical conjugate of human recombining Epidermic Growth Factor (hrEGF) and a combining protein P64k. The conjugation reaction produces this chemical conjugate in a controlled and reproducible manner. The preferred conjugate surprisingly increases immunogenic activity, leading to significant increases in anti-EGF antibody titers in humans. This innovative vaccine preparation offers more than one type of effective dose presentation, allowing for an increased immunization dose per patient without raising the frequency or number of immunization sites.
Career Highlights
Loany Calvo Gonzalez is affiliated with the Centro de Inmunología Molecular (CIM), where he continues to advance his research and development efforts. His work is pivotal in the ongoing fight against cancer, and his contributions are recognized within the scientific community.
Collaborations
Loany collaborates with talented individuals such as Gryssell Rodriguez Martinez and Lisel Vina Rodriguez, who contribute to the innovative environment at CIM. Their teamwork fosters a culture of creativity and scientific inquiry.
Conclusion
Loany Calvo Gonzalez exemplifies the spirit of innovation in the field of vaccine development. His work not only addresses critical health challenges but also paves the way for future advancements in cancer treatment.